CLINICAL_TRIALS
trial_result
· 2023-08-04
Clinical Trial Update: Bortezomib in Treating Patients With Mantle Cell Lymphoma [Phase 2]
Summary
Phase 2 trial update evaluating bortezomib in mantle cell lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NCIC Clinical Trials Group | Conditions: Lymphoma | Phase 2 | Status: COMPLETED